419 related articles for article (PubMed ID: 27497430)
1. Process performance and product quality in an integrated continuous antibody production process.
Karst DJ; Steinebach F; Soos M; Morbidelli M
Biotechnol Bioeng; 2017 Feb; 114(2):298-307. PubMed ID: 27497430
[TBL] [Abstract][Full Text] [Related]
2. Integrated continuous production of recombinant therapeutic proteins.
Warikoo V; Godawat R; Brower K; Jain S; Cummings D; Simons E; Johnson T; Walther J; Yu M; Wright B; McLarty J; Karey KP; Hwang C; Zhou W; Riske F; Konstantinov K
Biotechnol Bioeng; 2012 Dec; 109(12):3018-29. PubMed ID: 22729761
[TBL] [Abstract][Full Text] [Related]
3. Modulation and modeling of monoclonal antibody N-linked glycosylation in mammalian cell perfusion reactors.
Karst DJ; Scibona E; Serra E; Bielser JM; Souquet J; Stettler M; Broly H; Soos M; Morbidelli M; Villiger TK
Biotechnol Bioeng; 2017 Sep; 114(9):1978-1990. PubMed ID: 28409838
[TBL] [Abstract][Full Text] [Related]
4. Design and operation of a continuous integrated monoclonal antibody production process.
Steinebach F; Ulmer N; Wolf M; Decker L; Schneider V; Wälchli R; Karst D; Souquet J; Morbidelli M
Biotechnol Prog; 2017 Sep; 33(5):1303-1313. PubMed ID: 28691347
[TBL] [Abstract][Full Text] [Related]
5. Process-wide control and automation of an integrated continuous manufacturing platform for antibodies.
Feidl F; Vogg S; Wolf M; Podobnik M; Ruggeri C; Ulmer N; Wälchli R; Souquet J; Broly H; Butté A; Morbidelli M
Biotechnol Bioeng; 2020 May; 117(5):1367-1380. PubMed ID: 32022243
[TBL] [Abstract][Full Text] [Related]
6. Improving product quality and productivity of bispecific molecules through the application of continuous perfusion principles.
Gomez N; Lull J; Yang X; Wang Y; Zhang X; Wieczorek A; Harrahy J; Pritchard M; Cano DM; Shearer M; Goudar C
Biotechnol Prog; 2020 Jul; 36(4):e2973. PubMed ID: 31991523
[TBL] [Abstract][Full Text] [Related]
7. Biomanufacturing evolution from conventional to intensified processes for productivity improvement: a case study.
Xu J; Xu X; Huang C; Angelo J; Oliveira CL; Xu M; Xu X; Temel D; Ding J; Ghose S; Borys MC; Li ZJ
MAbs; 2020 Jan; 12(1):1770669. PubMed ID: 32425110
[TBL] [Abstract][Full Text] [Related]
8. Development of at-line assay to monitor charge variants of MAbs during production.
St Amand MM; Ogunnaike BA; Robinson AS
Biotechnol Prog; 2014; 30(1):249-55. PubMed ID: 24382831
[TBL] [Abstract][Full Text] [Related]
9. Defining process design space for monoclonal antibody cell culture.
Abu-Absi SF; Yang L; Thompson P; Jiang C; Kandula S; Schilling B; Shukla AA
Biotechnol Bioeng; 2010 Aug; 106(6):894-905. PubMed ID: 20589669
[TBL] [Abstract][Full Text] [Related]
10. WAVE-based intensified perfusion cell culture for fast process development.
Lang Z; Yan S; Xiong Q; Chen G
Biotechnol Lett; 2023 Sep; 45(9):1117-1131. PubMed ID: 37382759
[TBL] [Abstract][Full Text] [Related]
11. Perfusion seed cultures improve biopharmaceutical fed-batch production capacity and product quality.
Yang WC; Lu J; Kwiatkowski C; Yuan H; Kshirsagar R; Ryll T; Huang YM
Biotechnol Prog; 2014; 30(3):616-25. PubMed ID: 24574326
[TBL] [Abstract][Full Text] [Related]
12. Integrated continuous biomanufacturing platform with ATF perfusion and one column chromatography operation for optimum resin utilization and productivity.
Kamga MH; Cattaneo M; Yoon S
Prep Biochem Biotechnol; 2018 May; 48(5):383-390. PubMed ID: 29509101
[TBL] [Abstract][Full Text] [Related]
13. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
[TBL] [Abstract][Full Text] [Related]
14. Case Study: an accelerated 8-day monoclonal antibody production process based on high seeding densities.
Padawer I; Ling WL; Bai Y
Biotechnol Prog; 2013; 29(3):829-32. PubMed ID: 23596148
[TBL] [Abstract][Full Text] [Related]
15. Continuous and Integrated Expression and Purification of Recombinant Antibodies.
Vogg S; Wolf MKF; Morbidelli M
Methods Mol Biol; 2018; 1850():147-178. PubMed ID: 30242686
[TBL] [Abstract][Full Text] [Related]
16. Exploring the linkage between cell culture process parameters and downstream processing utilizing a plackett-burman design for a model monoclonal antibody.
Agarabi CD; Chavez BK; Lute SC; Read EK; Rogstad S; Awotwe-Otoo D; Brown MR; Boyne MT; Brorson KA
Biotechnol Prog; 2017 Jan; 33(1):163-170. PubMed ID: 27813291
[TBL] [Abstract][Full Text] [Related]
17. Application of a cell-once-through perfusion strategy for production of recombinant antibody from rCHO cells in a Centritech Lab II centrifuge system.
Kim BJ; Chang HN; Oh DJ
Biotechnol Prog; 2007; 23(5):1186-97. PubMed ID: 17691812
[TBL] [Abstract][Full Text] [Related]
18. Polymer-mediated flocculation of transient CHO cultures as a simple, high throughput method to facilitate antibody discovery.
Schmitt MG; Rajendra Y; Hougland MD; Boyles JS; Barnard GC
Biotechnol Prog; 2017 Sep; 33(5):1393-1400. PubMed ID: 28722325
[TBL] [Abstract][Full Text] [Related]
19. A new, integrated, continuous purification process template for monoclonal antibodies: Process modeling and cost of goods studies.
Xenopoulos A
J Biotechnol; 2015 Nov; 213():42-53. PubMed ID: 25959171
[TBL] [Abstract][Full Text] [Related]
20. Development of a scale down cell culture model using multivariate analysis as a qualification tool.
Tsang VL; Wang AX; Yusuf-Makagiansar H; Ryll T
Biotechnol Prog; 2014; 30(1):152-60. PubMed ID: 24124180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
